NEXT Biometrics Group ASA
NEXT Biometrics Group ASA Fundamental Analysis
NEXT Biometrics Group ASA (NXTBF) shows weak financial fundamentals with a PE ratio of -16.71, profit margin of -3.20%, and ROE of -57.58%. The company generates $0.0B in annual revenue with weak year-over-year growth of 1.09%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -248.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze NXTBF's fundamental strength across five key dimensions:
Efficiency Score
WeakNXTBF struggles to generate sufficient returns from assets.
Valuation Score
ModerateNXTBF shows balanced valuation metrics.
Growth Score
ModerateNXTBF shows steady but slowing expansion.
Financial Health Score
ExcellentNXTBF maintains a strong and stable balance sheet.
Profitability Score
WeakNXTBF struggles to sustain strong margins.
Key Financial Metrics
Is NXTBF Expensive or Cheap?
P/E Ratio
NXTBF trades at -16.71 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, NXTBF's PEG of 2.59 indicates potential overvaluation.
Price to Book
The market values NEXT Biometrics Group ASA at 12.56 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -5.40 times EBITDA. This is generally considered low.
How Well Does NXTBF Make Money?
Net Profit Margin
For every $100 in sales, NEXT Biometrics Group ASA keeps $-3.20 as profit after all expenses.
Operating Margin
Core operations generate -6.16 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-57.58 in profit for every $100 of shareholder equity.
ROA
NEXT Biometrics Group ASA generates $-57.40 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
NEXT Biometrics Group ASA generates limited operating cash flow of $-1.72M, signaling weaker underlying cash strength.
Free Cash Flow
NEXT Biometrics Group ASA generates weak or negative free cash flow of $-1.75M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.05 in free cash annually.
FCF Yield
NXTBF converts -21.20% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-16.71
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.59
vs 25 benchmark
P/B Ratio
Price to book value ratio
12.56
vs 25 benchmark
P/S Ratio
Price to sales ratio
16.72
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.05
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.21
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.58
vs 25 benchmark
ROA
Return on assets percentage
-0.57
vs 25 benchmark
ROCE
Return on capital employed
-1.41
vs 25 benchmark
How NXTBF Stacks Against Its Sector Peers
| Metric | NXTBF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -16.71 | 35.62 | Better (Cheaper) |
| ROE | -57.58% | 1161.00% | Weak |
| Net Margin | -320.22% | -126170.00% (disorted) | Weak |
| Debt/Equity | 0.05 | 0.46 | Strong (Low Leverage) |
| Current Ratio | 4.21 | 5.83 | Strong Liquidity |
| ROA | -57.40% | -308589.00% (disorted) | Weak |
NXTBF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews NEXT Biometrics Group ASA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-64.85%
Industry Style: Growth, Innovation, High Beta
DecliningEPS CAGR
90.32%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
80.63%
Industry Style: Growth, Innovation, High Beta
High Growth